FibroBiologics logo
FibroBiologics
FBLG | NASDAQ
Chart Builder DCF Calculator
$0.90
-$0.03 (-2.92%)
At close: Nov 16, 2026, 4:00 PM ET
$0.90
$0.00 (+0.38%)
After-hours: Nov 16, 2026, 7:30 PM ET

FibroBiologics Company Profile

Company profile explained

Company Profile

FibroBiologics, Inc. operates as a clinical-stage biopharmaceutical firm, advancing therapies derived from fibroblasts toward commercialization within the United States. The company's pipeline includes CybroCell, currently being developed to address degenerative disc disease; CYMS101, targeting multiple sclerosis; and CYWC628 for wound repair. Further demonstrating its broad scope, early-stage investigations are underway for CYTER915, aimed at restoring or enhancing thymus and/or spleen function; CYPS317, for psoriasis; and TCB190, designed to combat specific cancers. FibroBiologics was founded in 2021 and is situated in Houston, Texas.

Key Executives

Name Position
Peter O'Heeron Founder, Chairperson & Chief Executive Officer
Jason D. Davis Chief Financial Officer
Hamid Khoja Chief Scientific Officer
Ruben A. Garcia General Counsel

Latest SEC Filings

Date Type Title
Oct 19, 2026 EFFECT Filing
Oct 19, 2026 EFFECT Filing
Oct 13, 2026 POS AM Filing
Oct 13, 2026 POS AM Filing
Oct 13, 2026 D Filing
Oct 08, 2026 8-K Current Report
Sep 18, 2026 8-K Current Report
Sep 17, 2026 SC 13D Filing
Sep 15, 2026 4 Filing
Sep 16, 2026 D Filing
View All SEC Filings ➞
FibroBiologics
FibroBiologics logo
Country United States
IPO Date Feb 1, 2024
Industry Biotechnology
Sector Healthcare
Employees 15
CEO Peter O'Heeron

Contact Details

455 East Medical Center Boulevard Houston, Texas 77598 United States

Stock Details

Ticker Symbol FBLG
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001958777
CUSIP Number 31573L204
ISIN Number US31573L2043
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.